Editorial Volume 123 | Issue 5 | May 2015
Alternatives to PFASs: Perspectives on the Science
Linda S. Birnbaum1 and Philippe Grandjean2,3
1National Institute of Environmental Health Sciences and National Toxicology Program, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina, USA; 2University of Southern Denmark, Odense, Denmark; 3Harvard School of Public Health, Boston, Massachusetts, USA
Citation: Birnbaum LS, Grandjean P. 2015. Alternatives to PFASs: perspectives on the science. Environ Health Perspect 123:A104–A105; http://dx.doi.org/10.1289/ehp.1409657
In 2012 P.G. prepared an expert report on human health risks from exposure to perfluorinated compounds for the Minnesota Department of Health. L.S.B. declares she has no actual or potential competing financial interests.
Published: 1 May 2015
Poly- and perfluoroalkyl acids (PFASs) are ubiquitous in our lives. These chemicals are used as surfactants and as water and oil repellents in a variety of consumer products such as cosmetics, food packaging, furnishings, and clothing. Since their initial marketing more than 60 years ago, extensive research has demonstrated that the long-chain PFASs are highly persistent, bioaccumulative, and toxic (Buck et al. 2011). As a result, they are being phased out in many countries. However, controversy has emerged regarding the safety of the most common alternatives, the short-chain PFASs.
In the Madrid Statement on Poly- and Perfluoroalkyl Substances (PFASs), Blum et al. (2015) question the use of the entire class of PFASs, including short-chain fluorinated alternatives. Authored by 14 experts on the health effects, environmental fate, and policy issues concerning PFASs, the Madrid Statement documents the scientific consensus about the extreme environmental persistence, bioaccumulation, and potential toxicity of the overall class of PFASs (Blum et al. 2015). The statement defines a roadmap for scientists, governments, product manufacturers, purchasing organizations, and consumers to work together to limit the production and use of PFASs globally and to develop safer alternatives. Since it was presented at the 34th International Symposium on Halogenated Persistent Organic Pollutants, held 31 August–5 September 2014 in Madrid, Spain, 206 scientists and professionals from 40 countries have signed the Statement (Blum et al. 2015).
In a response to the Madrid Statement in this issue of EHP, the FluoroCouncil, which represents the world’s leading fluorotechnology companies, agrees that it “could support many of these policy recommendations if they were limited to long-chain PFASs” (Bowman 2015). The FluoroCouncil supports the call to action from the scientific and professional community to limit the production and environmental release of long-chain PFASs but states that “the short-chain PFAS substances studied to date are not expected to harm human health or the environment,” as they “are eliminated more rapidly from the body and are less toxic than long-chain substances” (Bowman 2015).
Although there is agreement regarding the shorter human half-lives of short-chain PFASs, the Helsingør Statement on PFASs (Scheringer et al. 2014) and other recent publications (Gomis et al. 2015; Wang et al. 2013, 2015) expressed concerns that fluorinated replacements are similar to the PFASs they replaced in terms of their chemical structure, environmental persistence, and hazardous potential for both the environment and humans. Given the fact that research raised concern about the long-chain PFASs for many years before action was taken and that global contamination and toxicity have been documented in the general population (Grandjean and Clapp 2014), potential risks of the short-chain PFASs should be taken into account when choosing replacements for the longer-chain compounds.
There are numerous similar examples of replacements for other chemical classes, in which banned or phased-out chemicals have been replaced with structurally similar chemicals. For example, polychlorinated biphenyls were replaced with chlorinated paraffins (National Toxicology Program 2014), polybrominated diphenyl ethers were replaced with other halogenated flame retardants (Birnbaum and Staskal 2004), and bisphenol A has been replaced with bisphenol S, at least in some applications (Rochester and Bolden 2015). Such straightforward replacement strategies may be cost effective in the short term. However, manufacturers may yet incur costs if the closely related alternative is later found to be as toxic as its predecessor. In fact, there are now multi-stakeholder efforts to improve the choice of alternatives to chemicals of concern (Birnbaum 2013; National Research Council 2014).
It has been difficult to find substitutes that match the function and performance level of PFASs. The chemical and thermal stability of PFASs as well as their hydrophobic and oleophobic properties provide unique material benefits (Buck et al. 2011). Significant innovation is thus required to find functional nonfluorinated alternatives to PFASs. The U.S. Environmental Protection Agency (EPA) recently recognized such innovation by awarding its 2014 Designing Greener Chemicals Award to a halogen-free firefighting foam (U.S. EPA 2014).
The growing global field of chemical alternatives assessment (CAA) provides tools and strategies for identifying compounds, materials, or product designs to substitute for the use of hazardous chemicals (Lavoie et al. 2010). For example, the California Department of Toxic Substances Control is using CAA in its Safer Consumer Products Program, whose objective is to remove toxic chemicals from products (California Department of Toxic Substances Control 2010). Many CAAs have already been conducted, and many more are in progress (e.g., Substitution in Practice of Prioritized Fluorinated Chemicals to Eliminate Diffuse Sources 2015). Conducting CAAs may prove valuable in clarifying the state of the science among potential alternatives to PFASs and providing guidance for future research and innovation. Nevertheless, finding an optimal alternative substance or technology is not straightforward, and CAAs may not always offer solutions. For instance, suitable nonfluorinated alternatives for certain functions of PFASs, such as stain resistance, appear to be lacking or underdeveloped.
Research is needed to understand the potential for adverse health effects from exposure to the short-chain PFASs, especially regarding low-dose endocrine disruption and immunotoxicity. In parallel, research is needed to find safe alternatives for all current uses of PFASs. The question is, should these chemicals continue to be used in consumer products in the meantime, given their persistence in the environment? And, in the absence of indisputably safe alternatives, are consumers willing to give up certain product functionalities, such as stain resistance, to protect themselves against potential health risks? These conundrums cannot be resolved by science alone but need to be considered in an open discussion informed by the scientific evidence.
Birnbaum LS. 2013. Designing safer chemicals. Environ Health Perspect 121(1):A9; doi: 10.1289/ehp.120634.
Birnbaum LS, Staskal DF. 2004. Brominated flame retardants: cause for concern? Environ Health Perspect 112(1):9–17; doi: 10.1289/ehp.6559.
Blum A, Balan SA, Scheringer M, Trier X, Goldenman G, Cousins IT, et al. 2015. The Madrid Statement on Poly- and Perfluoroalkyl Substances (PFASs). Environ Health Perspect 123(5):A107–A111; doi: 10.1289/ehp.1509934.
Bowman JS. 2015. Fluorotechnology is critical to modern life: the FluoroCouncil counterpoint to the Madrid Statement. Environ Health Perspect 123(5):A112–A113; doi: 10.1289/ehp.1509910.
Buck RC, Franklin J, Berger U, Conder JM, Cousins IT, de Voogt P, et al. 2011. Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integr Environ Assess Manag 7(4):513–541; doi: 10.1002/ieam.258.
California Department of Toxic Substances Control. 2010. Safer Consumer Products Homepage. Available: http://www.dtsc.ca.gov/SCP/index.cfm [accessed 6 April 2015].
Gomis MI, Wang Z, Scheringer M, Cousins IT. 2015. Modeling the physicochemical properties and environmental fate of emerging and novel per- and polyfluoroalkyl substances. Sci Total Environ 505:981–991; doi: 10.1016/j.scitotenv.2014.10.062.
Grandjean P, Clapp R. 2014. Changing interpretation of human health risks from perfluorinated compounds. Public Health Rep 129(6):482–485; PMID: [Pubmed].
Lavoie ET, Heine LG, Holder H, Rossi MS, Lee RE, Connor EA, et al. 2010. Chemical alternatives assessment: enabling substitution to safer chemicals. Environ Sci Technol 44(24):9244–9249; doi: 10.1021/es1015789.
National Research Council. 2014. A Framework to Guide Selection of Chemical Alternatives. Washington, DC:National Academies Press. Available: http://www.nap.edu/catalog/18872/a-framework-to-guide-selection-of-chemical-alternatives [accessed 6 April 2015].
National Toxicology Program. 2014. Chlorinated paraffins (C12, 60% chlorine). In: Report on Carcinogens, Thirteenth Edition. Research Triangle Park, NC:U.S. Department of Health and Human Services, Public Health Service. Available: http://ntp.niehs.nih.gov/pubhealth/roc/roc13/ [accessed 6 April 2015].
Rochester JR, Bolden AL. 2015. Bisphenol S and F: a systematic review and comparison of the hormonal activity of bisphenol A substitutes. Environ Health Perspect; doi: 10.1289/ehp.1408989.
Scheringer M, Trier X, Cousins IT, de Voogt P, Fletcher T, Wang Z, et al. 2014. Helsingør statement on poly- and perfluorinated alkyl substances (PFASs). Chemosphere 114:337–339; doi: 10.1016/j.chemosphere.2014.05.044.
Substitution in Practice of Prioritized Fluorinated Chemicals to Eliminate Diffuse Sources. 2015. Welcome to SUPFES Homepage. Available: http://www.supfes.eu/ [accessed 6 April 2015].
U.S. EPA (Environmental Protection Agency). 2014. 2014 Designing Greener Chemicals Award. Available: http://www2.epa.gov/green-chemistry/2014-designing-greener-chemicals-award [accessed 6 April 2015].
Wang Z, Cousins IT, Scheringer M, Hungerbühler K. 2013. Fluorinated alternatives to long-chain perfluoroalkyl carboxylic acids (PFCAs), perfluoroalkane sulfonic acids (PFSAs) and their potential precursors. Environ Int 60:242–248; doi: 10.1016/j.envint.2013.08.021.
Wang Z, Cousins IT, Scheringer M, Hungerbühler K. 2015. Hazard assessment of fluorinated alternatives to long-chain perfluoroalkyl acids (PFAAs) and their precursors: status quo, ongoing challenges and possible solutions. Environ Int 75:172–179; doi: 10.1016/j.envint.2014.11.013.
2015 Impact Factor
EHP is pleased to announce its new impact factor of 8.44, up from 7.98 last year. We thank our authors, associate editors, reviewers, and readers for their contributions and support.
CEHN June 2016 Article of the Month
“Intrauterine Inflammation and Maternal Exposure to Ambient PM2.5 during Preconception and Specific Periods of Pregnancy: The Boston Birth Cohort” (doi:10.1289/EHP243 ) has been selected by the Children’s Environmental Health Network (CEHN) as its June 2016 Article of the Month. These CEHN summaries discuss the potential policy implications of current children’s environmental health research.
Attention, Authors: New Submission System
EHP is now using Editorial Manager for manuscript submissions. All user accounts have been transferred to Editorial Manager—just log into Editorial Manager and reset your password. Editorial Manager offers an in-depth help index; for further questions, contact firstname.lastname@example.org. We hope you enjoy using our streamlined new submission system!
Sign Up to Receive E-mail Alerts
Recent Advance Publications
Feasibility of Deploying Inhaler Sensors to Identify the Impacts of Environmental Triggers and Built Environment Factors on Asthma Short-Acting Bronchodilator Use
Historical Prediction Modeling Approach for Estimating Long-Term Concentrations of PM2.5 in Cohort Studies before the 1999 Implementation of Widespread Monitoring
Towards More Comprehensive Projections of Urban Heat-Related Mortality: Estimates for New York City under Multiple Population, Adaptation, and Climate Scenarios
DNA Methylation Score as a Biomarker in Newborns for Sustained Maternal Smoking during Pregnancy
Perinatal DDT Exposure Induces Hypertension and Cardiac Hypertrophy in Adult Mice